Cardiovascular Complications of Gastrointestinal Diseases

It is known that 10% of all deaths in the United States have gastrointestinal disorders as their underlying cause. As many of these patients present with cardiovascular symptoms apparently related to their primary disorder, the relation between the cardiovascular and gastrointestinal systems has been under intensive investigation. Observational studies and case reports have suggested that gastroesophageal reflux disease can lead to atrial fibrillation and this relation is considered to implicate multiple mechanisms as inflammation, autoimmunity and exacerbated autonomic stimulation. Furthermore, current literature understands that atherosclerosis is a result of both traditional (e.g. diabetes mellitus, dyslipidemia) and non-traditional risk factors, such as chronic inflammation due to chronic infections (e.g. Helicobacter pylori and Hepatitis C virus infections) and chronic inflammatory diseases (e.g. inflammatory bowel disease). Numerous evidences of systolic and diastolic ventricular dysfunction have been reported in cirrhotic patients, being called cirrhotic cardiomyopathy and characterized by blunted contractile responsiveness to stress, diastolic dysfunction and electrophysiological abnormalities in the absence of underlying cardiac disease. Metabolic liver diseases are also related to cardiovascular injury through iron or copper overload in hemochromatosis and Wilson’s disease, respectively. This article intends to review cardiovascular complications due to primary gastrointestinal disorders and their potential physiopathological mechanisms, along with alert physicians of these still neglected gastrointestinal diseases presentations.

[1]  Peiying Zhang,et al.  Risk of cardiovascular disease in inflammatory bowel disease , 2016, Experimental and therapeutic medicine.

[2]  R. Vijayvergiya,et al.  Role of Helicobacter pylori infection in pathogenesis of atherosclerosis. , 2015, World journal of cardiology.

[3]  A. Makaryus,et al.  Inflammatory Bowel Disease as a Risk Factor for Premature Coronary Artery Disease , 2015, Journal of clinical medicine research.

[4]  A. Aggarwal,et al.  Helicobacter pylori: Does it add to risk of coronary artery disease. , 2015, World journal of cardiology.

[5]  Y. Weerakkody,et al.  Iron overload cardiomyopathy , 2014, Radiopaedia.org.

[6]  M. Papp,et al.  Pathophysiological and clinical approach to cirrhotic cardiomyopathy. , 2014, Journal of gastrointestinal and liver diseases : JGLD.

[7]  S. Bruley des Varannes,et al.  Atrial fibrillation in patients with gastroesophageal reflux disease: a comprehensive review. , 2014, World journal of gastroenterology.

[8]  O. Turriziani,et al.  Infectious burden and atherosclerosis: A clinical issue. , 2014, World journal of clinical cases.

[9]  F. Carrilho,et al.  Pro-atherosclerotic markers and cardiovascular risk factors one year after liver transplantation. , 2014, World journal of gastroenterology.

[10]  Z. Younossi,et al.  Hepatitis C Virus Infection and Coronary Artery Disease Risk: A Systematic Review of the Literature , 2014, Digestive Diseases and Sciences.

[11]  G. Buzás Metabolic consequences of Helicobacter pylori infection and eradication. , 2014, World journal of gastroenterology.

[12]  A. Lonardo,et al.  Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms. , 2014, World journal of gastroenterology.

[13]  Siddharth Singh,et al.  Risk of cerebrovascular accidents and ischemic heart disease in patients with inflammatory bowel disease: a systematic review and meta-analysis. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[14]  F. Bendtsen,et al.  Cirrhotic cardiomyopathy: pathogenesis and clinical relevance , 2014, Nature Reviews Gastroenterology &Hepatology.

[15]  C. Murray,et al.  Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study , 2014, Circulation.

[16]  Y. Fouad,et al.  Hepato-cardiac disorders. , 2014, World journal of hepatology.

[17]  M. Bernardi,et al.  Interactions of the heart and the liver. , 2013, European heart journal.

[18]  A. Verma,et al.  Atrial fibrillation ablation in patients with gastroesophageal reflux disease or irritable bowel syndrome—the heart to gut connection! , 2013, Journal of Interventional Cardiac Electrophysiology.

[19]  Han‐Chieh Lin,et al.  The heart: Pathophysiology and clinical implications of cirrhotic cardiomyopathy , 2012, Journal of the Chinese Medical Association : JCMA.

[20]  Seth D. Crockett,et al.  Burden of gastrointestinal disease in the United States: 2012 update. , 2012, Gastroenterology.

[21]  M. Farkouh,et al.  Are patients with inflammatory bowel disease at increased risk of coronary artery disease? , 2012, The American journal of medicine.

[22]  S. Harrison,et al.  Cardiovascular Disease and Nonalcoholic Fatty Liver Disease: Does Histologic Severity Matter? , 2012, Journal of clinical gastroenterology.

[23]  P. Velagapudi,et al.  Atrial Fibrillation and Acid Reflux Disease , 2012, Clinical cardiology.

[24]  D. Farmakis,et al.  Contemporary Reviews in Cardiovascular Medicine Iron Overload Cardiomyopathy in Clinical Practice , 2011 .

[25]  H. Makhlouf,et al.  Pathologic criteria for nonalcoholic steatohepatitis: Interprotocol agreement and ability to predict liver‐related mortality , 2011, Hepatology.

[26]  G. Oudit,et al.  Iron-overload cardiomyopathy: pathophysiology, diagnosis, and treatment. , 2010, Journal of cardiac failure.

[27]  S. Lubitz,et al.  Sudden cardiac death in infiltrative cardiomyopathies: sarcoidosis, scleroderma, amyloidosis, hemachromatosis. , 2008, Progress in cardiovascular diseases.

[28]  N. Lakkis,et al.  Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data. , 2007, Journal of the American College of Cardiology.

[29]  J. Konturek,et al.  Helicobacter pylori infection in coronary artery disease. , 2006, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[30]  P. Kuan Cardiac Wilson's disease. , 1987, Chest.

[31]  F. Purrello,et al.  Cardiovascular dysfunction in patients with liver cirrhosis , 2015, Annals of gastroenterology.

[32]  F. Wong Cirrhotic cardiomyopathy , 2009, Hepatology international.

[33]  S. Factor,et al.  The cardiomyopathy of Wilson's disease , 2004, Virchows Archiv A.